Lia Holmgren: HIMS faces resistance with next level at $40 as GEX builds at $50

Lia Holmgren: HIMS faces resistance with next level at $40 as GEX builds at $50
HIMS tests resistance, GEX builds higher

Lia Holmgren highlights that HIMS is currently testing a resistance level, with the next key target set at $40. There is also notable GEX activity now building at $50.

Holmgren further mentions that the Trump administration plans to ease restrictions on testosterone therapy.

Holmgren has previously advised caution on SPCX stock due to limited liquidity and low trading volume. She has also noted technical patterns in the healthcare sector, observing XLV testing resistance levels. These past comments add further context to her current analysis of HIMS price action.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.